High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals

Recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants Mu and C.1.2 have spike proteins with mutations that may confer resistance to natural and vaccine-elicited antibodies. Analysis of neutralizing antibody titers in the sera of vaccinated individuals without prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Takuya, Zhou, Hao, Dcosta, Belinda M., Samanovic, Marie I., Cornelius, Amber, Herati, Ramin S., Mulligan, Mark J., Landau, Nathaniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687746/
https://www.ncbi.nlm.nih.gov/pubmed/34982967
http://dx.doi.org/10.1016/j.celrep.2021.110237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687746/
https://www.ncbi.nlm.nih.gov/pubmed/34982967
http://dx.doi.org/10.1016/j.celrep.2021.110237

Ejemplares similares